Application no. and date | 08797363.2 (espacenet) (Federated) (European Patent Register), 20080807 | Patent/reg. no. and date | DK/EP 2182902, 20150107 | Publication date | 20100512 | Priority no. and date | US 954501 P, 20070807 | EP pub. no. and date |
EP 2182902 20100512 | Effective date | | Applicant/owner | Acelrx Pharmaceuticals, Inc., 575 Chesapeake Drive
Redwood City, CA 94063, US | Applicant ref. no. | P21140DKEP | Inventor | TZANNIS, Stelios, 35241 Wycombe Place
Newark, California 94560, US, PALMER, Pamela, 140 Vasquez Avenue
San Francisco, California 94127, US, SCHRECK, Thomas, 140 Willowbrook Drive
Portola Valley, California 94028, US | Representative | Patrade A/S, Ceresbyen 75, 8000 Århus C | Opponent | | IPC Class | A61K 31/4535 (2006.01) , A61K 31/5517 (2006.01) , A61K 9/00 (2006.01) , A61K 9/70 (2006.01) , A61P 25/20 (2006.01) | Title | Sammensætninger omfattende sufentanil og triazolam til proceduresedering og analgesi under anvendelse af orale transmucosale doseringsformer | Int. application no. | US2008072445 | Int. publication no. | WO2009021106 | Related patent (certificate) | | Status | Bortfaldet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|